Formosa Laboratories (Taiwan) Performance
| 4746 Stock | TWD 76.00 0.40 0.53% |
The firm shows a Beta (market volatility) of 0.45, which means possible diversification benefits within a given portfolio. As returns on the market increase, Formosa Laboratories' returns are expected to increase less than the market. However, during the bear market, the loss of holding Formosa Laboratories is expected to be smaller as well. At this point, Formosa Laboratories has a negative expected return of -0.31%. Please make sure to confirm Formosa Laboratories' treynor ratio, value at risk, and the relationship between the total risk alpha and maximum drawdown , to decide if Formosa Laboratories performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Formosa Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors. ...more
| Begin Period Cash Flow | 581 M | |
| Total Cashflows From Investing Activities | -589.5 M | |
| Free Cash Flow | -202.7 M |
Formosa |
Formosa Laboratories Relative Risk vs. Return Landscape
If you would invest 9,410 in Formosa Laboratories on September 2, 2024 and sell it today you would lose (1,810) from holding Formosa Laboratories or give up 19.23% of portfolio value over 90 days. Formosa Laboratories is generating negative expected returns and assumes 1.9251% volatility on return distribution over the 90 days horizon. Simply put, 17% of stocks are less volatile than Formosa, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Formosa Laboratories Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Formosa Laboratories' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Formosa Laboratories, and traders can use it to determine the average amount a Formosa Laboratories' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1636
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 4746 |
Estimated Market Risk
| 1.93 actual daily | 17 83% of assets are more volatile |
Expected Return
| -0.31 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Formosa Laboratories is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Formosa Laboratories by adding Formosa Laboratories to a well-diversified portfolio.
Formosa Laboratories Fundamentals Growth
Formosa Stock prices reflect investors' perceptions of the future prospects and financial health of Formosa Laboratories, and Formosa Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Formosa Stock performance.
| Return On Equity | -0.0393 | |||
| Return On Asset | 0.0034 | |||
| Profit Margin | (0.03) % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 9.7 B | |||
| Shares Outstanding | 120.26 M | |||
| Price To Earning | 97.70 X | |||
| Price To Book | 1.02 X | |||
| Price To Sales | 2.49 X | |||
| Revenue | 3.14 B | |||
| EBITDA | 1.59 B | |||
| Cash And Equivalents | 756.11 M | |||
| Cash Per Share | 7.64 X | |||
| Total Debt | 1.91 B | |||
| Debt To Equity | 78.60 % | |||
| Book Value Per Share | 60.24 X | |||
| Cash Flow From Operations | 311.16 M | |||
| Earnings Per Share | (1.85) X | |||
| Total Asset | 12.02 B | |||
| Retained Earnings | 680 M | |||
| Current Asset | 2.31 B | |||
| Current Liabilities | 2.04 B | |||
About Formosa Laboratories Performance
Evaluating Formosa Laboratories' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Formosa Laboratories has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Formosa Laboratories has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Formosa Laboratories, Inc. produces and sells active pharmaceutical ingredients and UV-filters worldwide. The company was founded in 1995 and is based in Taoyuan, Taiwan. FORMOSA LABORATORIES operates under Drug Manufacturers - Specialty Generic classification in Taiwan and is traded on Taiwan Stock Exchange.Things to note about Formosa Laboratories performance evaluation
Checking the ongoing alerts about Formosa Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Formosa Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Formosa Laboratories generated a negative expected return over the last 90 days | |
| Formosa Laboratories has accumulated NT$1.91 Billion in debt which can lead to volatile earnings | |
| About 21.0% of the company shares are owned by insiders or employees |
- Analyzing Formosa Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Formosa Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Formosa Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Formosa Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Formosa Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Formosa Laboratories' stock. These opinions can provide insight into Formosa Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Formosa Stock Analysis
When running Formosa Laboratories' price analysis, check to measure Formosa Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Formosa Laboratories is operating at the current time. Most of Formosa Laboratories' value examination focuses on studying past and present price action to predict the probability of Formosa Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Formosa Laboratories' price. Additionally, you may evaluate how the addition of Formosa Laboratories to your portfolios can decrease your overall portfolio volatility.